Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.

ABSTRACT:

SUBMITTER: Tabernero J 

PROVIDER: S-EPMC7513622 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature